Piedmont Heart Institute Napa Valley Cardiology Conference
Avatar

The Stroke Prevention War: DOAC vs Warfarin vs LAA Device Closure

By Piedmont Heart Institute Napa Valley Cardiology Conference FEATURING Thomas Deering
November 15, 2019
1 Comment
Login to view comments. Click here to Login

Related Content

AUTOPLAY
Scottsdale Interventional Forum 2021

Scottsdale Interventional Forum 2021 (Hybrid)

Wed, Mar 10, 2021
25:21
Congenital and Structural Interventions

LAA Closure for Atrial Fibrillation using Occlusion Device

Feat. H. Sievert
14:39
Lankenau

Management of AF patients with ACS

Feat. P. Kowey, D. Ice
19:47
Complex Coronary Cases Symposium 2019

Therapy Post PCI: What Is the Rationale for DAPT and OAC? When to Use Trip…

Feat. U. Baber
16:37
Cardiopulmonary Research Science and Technology Institute

Anticoagulation for Stroke Prevention in Patients with Atrial Fibrillation

Feat. G. Stone
25:22
Scottsdale Interventional Forum 2020 Virtual

Why Is the Left Atrial Appendage Occlusion Underutilized?

Feat. J. Lasala
20:30
Scripps 9th Annual Structural Heart Intervention and Imaging 2020: A Practical Approach

Transcatheter LAA Closure for Stroke Prevention: Current Data and Future D…

Feat. M. Price
13:21
The North American Thrombosis Forum (NATF)

Novel Trials and Guideline Updates from the 2020 ESC Congress: When to Use…

Feat. C. Cruff
12:55
Cardiology Fiesta 2018

Heart Failure and Atrial Fibrillation – What Is the Right Approach for You…

Feat. J. Pillarisetti
15:52
ARCH Advanced Revascularization Symposium

LAA Closure: Patient Selection, Imaging and Anti-Thrombotic Therapy

Feat. S. Yakubov
30:04
Scripps Health: 2019 Sixth Annual Clinical Advances in Heart Failure and Arrhythmias

Outpatient Management of Atrial Fibrillation

Feat. N. Olson
19:28
Northwestern Medicine: 7th Annual Cardiovascular Update

Re-Visiting the Natural History of AF: Who is at Risk of Stroke and What a…

Feat. R. Passman
21:41
Cardiology Fiesta 2018

Results from the CABANA Trial: What Does it Mean

Feat. D. Packer
20:15
Cardiology Fiesta 2017

The Guidelines: Current Recommendations for TAVR, Left Atrial Appendage Oc…

Feat. S. Bailey
14:25
California Heart Rhythm Symposium

Therapies for Atrial Fibrillation in the Next Decade

Feat. H. Calkins
19:11
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

Rationale and Practical Aspects for using NOAC’s to Treat Afib and VTE

Feat. D. Blanchard
19:58
George Davis

Anticoagulant Reversal Agents

17:08
Jonathan Piccini

Which Direct Acting Oral Anticoagulant for my Patient with Chronic Kidney …

32:34
Cardiovascular Disease Management: A Case-Based Approach 2018

Atrial Fibrillation: What Is the Best Approach to Treat and Control? A Pra…

Feat. J. Bunch
23:00
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

What’s the Best Way to Manage Patients with Atrial Fibrillation?

Feat. J. Hsu
13:43
American Heart & Vascular Institute

Review of Oral Anticoagulants for Atrial Fibrillation: What Are the Indica…

Feat. V. Le